Reaction Details Report a problem with these data
Target
Androgen receptor [633-919]
Ligand
BDBM50425732
Substrate
n/a
Meas. Tech.
Affinity Assay
Ki
3641±n/a nM
Citation
 Narayanan, R; Miller, DD; Ponnusamy, T; Hwang, D; He, Y Selective androgen receptor degrader (SARD) ligands and methods of use thereof US Patent  US11230523 Publication Date 1/25/2022 
Target
Name:
Androgen receptor [633-919]
Synonyms:
ANDR_HUMAN | AR | Androgen receptor (633-919) | DHTR | NR3C4
Type:
aa 633-919
Mol. Mass.:
33165.80
Organism:
Homo sapiens (Human)
Description:
P10275[633-919]
Residue:
287
Sequence:
KKLGNLKLQEEGEASSTTSPTEETTQKLTVSHIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHT
  
Inhibitor
Name:
BDBM50425732
Synonyms:
ENZALUTAMIDE | US10053433, FC 4.129 | US10806720, Compound Enzalutamide | US11230523, Compound Enzalutamide | US11648234, Compound Enzalutamide | US20230382870, Enzalutamide | Xtandi
Type:
Small organic molecule
Emp. Form.:
C21H16F4N4O2S
Mol. Mass.:
464.436
SMILES:
CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C1(C)C)c1ccc(C#N)c(c1)C(F)(F)F
Structure:
Search PDB for entries with ligand similarity: